Robert Nelsen's Net Worth

$16.7 Million

Estimate Recalculated May 31, 2025 01:59AM EST

Who is Robert Nelsen

Robert Nelsen has an estimated net worth of $16.7 Million. This is based on reported shares across multiple companies, which include PHASERX, INC., Neumora Therapeutics, Inc., ADESTO TECHNOLOGIES Corp, IMPINJ INC, VBI VACCINES INC., NeurogesX Inc, Receptos, Inc., Gossamer Bio, Inc., Scholar Rock Holding Corp, Erasca, Inc., Pulmatrix, Inc., Verve Therapeutics, Inc., bluebird bio, Inc., Metacrine, Inc., Unity Biotechnology, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., Homology Medicines, Inc., Achaogen Inc, Trubion Pharmaceuticals, Inc, Beam Therapeutics Inc., Syros Pharmaceuticals, Inc., XTERA COMMUNICATIONS, INC., CELEBRATE EXPRESS, INC., Boundless Bio, Inc., Rapport Therapeutics, Inc., Sana Biotechnology, Inc., KYTHERA BIOPHARMACEUTICALS INC, ALNYLAM PHARMACEUTICALS INC, Lyell Immunopharma, Inc., AGIOS PHARMACEUTICALS INC, DA32 Life Science Tech Acquisition Corp., 908 Devices Inc., Karuna Therapeutics, Inc., Quanterix Corp, Revolution Healthcare Acquisition Corp., Denali Therapeutics Inc., FATE THERAPEUTICS INC, Twist Bioscience Corp, Sage Therapeutics, Inc., Vir Biotechnology, Inc., Bellerophon Therapeutics, Inc., XCYTE THERAPIES INC, Juno Therapeutics, Inc., Prime Medicine, Inc., ILLUMINA INC, and ADOLOR CORP.

SEC CIK

Robert Nelsen's CIK is 0001219042

Past Insider Trading and Trends

2021 was Robert Nelsen's most active year for acquiring shares with 24 total transactions. Robert Nelsen's most active month to acquire stocks was the month of May. 2018 was Robert Nelsen's most active year for disposing of shares, totalling 5 transactions. Robert Nelsen's most active month to dispose stocks was the month of February. 2015 saw Robert Nelsen paying a total of $1,126,371.76 for 206,673 shares, this is the most they've acquired in one year. In 2018 Robert Nelsen cashed out on 90,058 shares for a total of $6,326,766.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMPINJ INC

Investor
Updated Aug 30, 2016
Form 4/A
7.23%
92.09K
$10.73
$204.50
Aug 30, 2016
1.37M
Options
Jul 26
Form 4
6.81%
86.77K
$11.66
$68.32
Jul 26, 2016
1.36M
Options
Jul 26
Form 3
Jul 20, 2016
Showing 3 results

NeurogesX Inc

Investor
Updated Jun 11, 2012
Form 4
-50.00%
-10.00K
Jun 11, 2012
10.00K
Grant
Jun 07
Form 4
50.00K
Feb 09, 2012
50.00K
Grant
Feb 07
Form 4/A
71.38%
1.74M
$1.65
$2.88M
Sep 01, 2011
4.19M
Purchase
Jul 26
Form 4
107.07%
2.62M
$0.90
$3.00M
Jul 26, 2011
5.06M
Purchase
Jul 26
Form 4
107.07%
2.62M
$0.90
$3.00M
Jul 25, 2011
5.06M
Purchase
Jul 21
Form 4
10.00K
Jun 06, 2011
10.00K
Grant
Jun 02
Form 4
10.00K
Jun 04, 2010
10.00K
Grant
Jun 02
Form 4
33.33%
5.00K
Oct 19, 2009
20.00K
Grant
Oct 15
Form 4
50.00%
5.00K
May 29, 2009
15.00K
Grant
May 28
Form 4
100.00%
5.00K
May 30, 2008
10.00K
Grant
May 29
Form 4
24.10%
496.82K
$3.16
$2.38M
Dec 27, 2007
2.56M
Purchase
Dec 24
Form 4/A
5.00K
Jun 20, 2007
5.00K
Grant
Jun 05
Form 4
5.00K
Jun 08, 2007
5.00K
Grant
Jun 05
Form 4
-92.72%
-32.26M
May 08, 2007
2.53M
Options
May 07
Form 4
227.00K
$11.00
$2.50M
May 04, 2007
227.00K
Purchase
May 02
Form 3
May 01, 2007
Showing 16 results

XTERA COMMUNICATIONS, INC.

Investor
Updated Oct 13, 2016
Form 4
20.04%
83.50K
Oct 13, 2016
500.17K
Purchase
Oct 11
Form 4
150.00%
250.00K
Sep 28, 2016
416.67K
Purchase
Sep 27
Form 4
166.67K
Sep 15, 2016
166.67K
Purchase
Sep 13
Form 4
-91.15%
-38.82M
$5.00
$1.50M
Nov 18, 2015
3.77M
Buy-Options
Nov 17
Form 3
Nov 12, 2015
20.35K
Showing 5 results

Trubion Pharmaceuticals, Inc

Investor
Updated Nov 01, 2010
Form 4
-100.00%
-2.36M
Nov 01, 2010
Sale
Oct 28
Form 4
Oct 25, 2006
2.36M
Options
Oct 23
Form 4
187.86%
44.64K
$13.00
$580.32K
Oct 19, 2006
68.40K
Purchase
Oct 17
Form 3
Oct 17, 2006
23.92K
Showing 4 results

CELEBRATE EXPRESS, INC.

Investor
Updated Sep 03, 2008
Form 4
-100.00%
-1.04M
Sep 03, 2008
Disposition
Aug 29
Form 4
9.55%
89.85K
Oct 27, 2004
1.03M
Options
Oct 25
Form 3
Oct 19, 2004
89.85K
Showing 3 results

PHASERX, INC.

Investor
Updated May 25, 2016
Form 4
12.99%
329.33K
$2.51
$4.99M
May 25, 2016
2.87M
Purchase
May 23
Form 3/A
May 23, 2016
2.53M
Form 3
May 17, 2016
2.49M
Showing 3 results

Neumora Therapeutics, Inc.

Investor
Updated Dec 12, 2023
Form 4
102.76%
1.88M
Dec 12, 2023
31.93M
Acquisition
Dec 08
Form 4
0.85%
35.01K
$11.77
$412.14K
Nov 15, 2023
4.13M
Purchase
Nov 13 - Nov 14
Form 4
3.55%
140.60K
$10.98
$1.54M
Nov 13, 2023
4.10M
Purchase
Nov 08 - Nov 10
Form 4
2.48%
95.69K
$11.49
$1.10M
Nov 07, 2023
3.96M
Purchase
Nov 03 - Nov 07
Form 4
2.02%
76.51K
$13.68
$1.05M
Sep 29, 2023
3.86M
Purchase
Sep 28 - Sep 29
Form 4
1.57%
58.50K
$11.97
$700.46K
Sep 27, 2023
3.78M
Purchase
Sep 26 - Sep 27
Form 4
2.78%
100.74K
$11.19
$1.13M
Sep 25, 2023
3.72M
Purchase
Sep 22 - Sep 25
Form 4
5.35%
1.50M
$17.00
Sep 20, 2023
29.55M
Purchase
Sep 19
Form 3
Sep 14, 2023
10.62M
Showing 9 results

ADESTO TECHNOLOGIES Corp

Investor
Updated Nov 03, 2015
Form 4
71.22%
946.95K
Nov 03, 2015
2.28M
Options
Oct 30
Form 4
400.00K
$5.00
$2.00M
Oct 28, 2015
400.00K
Purchase
Oct 26
Form 3
Oct 26, 2015
Showing 3 results

VBI VACCINES INC.

Investor
Updated Aug 17, 2015
Form 4
19.13%
650.00K
$2.10
$1.37M
Aug 17, 2015
4.05M
Grant
Aug 13
Form 3/A
Aug 17, 2015
3.40M
Form 3
Aug 04, 2014
3.40M
Showing 3 results

Receptos, Inc.

Investor
Updated May 15, 2014
Form 4
-2.03%
-45.38K
$29.66
-$1.35M
May 15, 2014
2.19M
Sale
May 13 - May 14
Form 4
-83.90%
-11.63M
$14.00
May 14, 2013
2.23M
Buy-Options
May 14
Form 3
May 08, 2013
114.29K
Showing 3 results

Gossamer Bio, Inc.

Investor
Updated Feb 12, 2019
Form 4
-77.78%
-28.20M
Feb 12, 2019
8.06M
Options
Feb 12
Form 3
Feb 07, 2019
Showing 2 results

Scholar Rock Holding Corp

Investor
Updated May 31, 2018
Form 4
-64.97%
-4.89M
May 31, 2018
2.64M
Options
May 29
Form 3
May 23, 2018
Showing 2 results

Erasca, Inc.

Investor
Updated Jul 20, 2021
Form 4
-16.67%
-2.21M
Jul 20, 2021
11.06M
Options
Jul 20
Form 3
Jul 15, 2021
Showing 2 results

Pulmatrix, Inc.

Investor
Updated Apr 12, 2018
Form 4
Apr 12, 2018
Form 4
150.89%
3.45M
Apr 05, 2018
5.74M
Purchase
Apr 03
Form 4/A
797.51K
Jun 25, 2015
797.51K
Grant
Jun 15
Form 4
3.10M
$6.88
Jun 17, 2015
3.10M
Purchase
Jun 15 - Jun 16
Form 3
Jun 17, 2015
Showing 5 results

Verve Therapeutics, Inc.

Investor
Updated Jun 23, 2021
Form 4
-89.20%
-20.72M
Jun 23, 2021
2.51M
Options
Jun 21
Form 3
Jun 16, 2021
Showing 2 results

bluebird bio, Inc.

Investor
Updated Jun 26, 2013
Form 4
-94.73%
-32.23M
Jun 26, 2013
1.79M
Options
Jun 24
Form 3
Jun 18, 2013
Showing 2 results

Metacrine, Inc.

Investor
Updated Sep 22, 2020
Form 4
8.49%
230.00K
$13.00
Sep 22, 2020
2.94M
Purchase
Sep 18
Form 3
Sep 15, 2020
Showing 2 results

Unity Biotechnology, Inc.

Investor
Updated Jun 22, 2020
Form 4
25.00K
Jun 22, 2020
25.00K
Grant
Jun 18
Form 4
25.00K
Jun 24, 2019
10.07M
Grant
Jun 20
Form 4
May 07, 2018
10.05M
Options
May 07
Form 4
40.68K
May 04, 2018
40.68K
Grant
May 02
Form 3
May 03, 2018
39.55K
Form 3
May 02, 2018
39.55K
Showing 6 results

Codiak BioSciences, Inc.

Investor
Updated Sep 15, 2022
Form 4
259.46%
10.00M
$1.50
$7.50M
Sep 15, 2022
13.85M
Purchase
Sep 13
Form 4
-72.59%
-23.31M
$15.00
$3.53M
Oct 20, 2020
8.80M
Buy-Options
Oct 16
Form 3
Oct 13, 2020
63.96K
Showing 3 results

Sienna Biopharmaceuticals, Inc.

Investor
Updated Feb 26, 2019
Form 4
59.61%
2.17M
$2.50
$5.41M
Feb 26, 2019
5.80M
Purchase
Feb 22
Form 4
59.61%
2.17M
$2.50
$5.41M
Feb 26, 2019
5.80M
Purchase
Feb 22
Form 4
10.00K
Jun 05, 2018
10.00K
Grant
Jun 01
Form 4
5.32K
Nov 02, 2017
5.32K
Grant
Nov 01
Form 4
Aug 01, 2017
3.63M
Options
Aug 01
Form 3
Jul 26, 2017
Showing 6 results

Homology Medicines, Inc.

Investor
Updated May 23, 2019
Form 4
-4.94%
-300.00K
May 23, 2019
5.77M
Disposition
May 21
Form 4
Apr 04, 2018
6.07M
Options
Apr 02
Form 3
Mar 27, 2018
Showing 3 results

Achaogen Inc

Investor
Updated Mar 11, 2014
Form 3
Mar 11, 2014
Showing 1 results

Beam Therapeutics Inc.

Investor
Updated Jul 02, 2021
Form 4
-6.24%
-391.95K
Jul 02, 2021
5.89M
Disposition
Jun 30
Form 4
-7.52%
-783.90K
Jun 29, 2021
9.64M
Disposition
Jun 25 - Jun 29
Form 4
-5.30%
-395.31K
Apr 02, 2021
7.06M
Disposition
Mar 31
Form 4
-6.50%
-790.63K
Mar 22, 2021
11.37M
Disposition
Mar 18 - Mar 22
Form 4
Feb 11, 2020
8.24M
Options
Feb 10
Form 3
Feb 05, 2020
Showing 6 results

Syros Pharmaceuticals, Inc.

Investor
Updated Jul 17, 2019
Form 4
-0.73%
-63.00K
$8.00
-$489.28K
Jul 17, 2019
8.54M
Sale
Jul 15 - Jul 17
Form 4
-3.75%
-167.50K
$7.83
-$1.31M
Mar 14, 2019
4.31M
Sale
Mar 12 - Mar 14
Form 4
-3.55%
-164.58K
$6.80
-$1.12M
Mar 11, 2019
4.47M
Sale
Mar 07 - Mar 11
Form 4/A
11.00K
Sep 22, 2017
11.00K
Grant
Jun 08
Form 4
11.00K
Jun 12, 2017
11.00K
Grant
Jun 08
Form 4
22.00K
Sep 19, 2016
22.00K
Grant
Sep 15
Form 4
-69.70%
-10.67M
$12.50
Jul 06, 2016
4.64M
Buy-Options
Jul 06
Form 3
Jun 29, 2016
213.33K
Showing 8 results

Boundless Bio, Inc.

Investor
Updated Apr 04, 2024
Form 4
4.81%
200.00K
$16.00
$3.20M
Apr 04, 2024
4.36M
Purchase
Apr 02
Form 3
Mar 27, 2024
68.37K
Showing 2 results

Rapport Therapeutics, Inc.

Investor
Updated Jun 10, 2024
Form 4
-88.32%
-28.20M
Jun 10, 2024
3.73M
Options
Jun 10
Form 3
Jun 06, 2024
Showing 2 results

Sana Biotechnology, Inc.

Investor
Updated Jul 15, 2024
Form 4/A
65.00K
Jul 15, 2024
65.00K
Grant
Jun 06
Form 4
54.28K
Jun 07, 2024
54.28K
Grant
Jun 06
Form 4
5.39%
1.82M
$5.50
$10.00M
Feb 12, 2024
45.87M
Purchase
Feb 08
Form 4
65.00K
Jun 12, 2023
65.00K
Grant
Jun 08
Form 4
65.61%
536.00
Jan 06, 2023
44.06M
Grant
Jan 05
Form 4
64.72%
321.00
Oct 06, 2022
44.06M
Grant
Oct 05
Form 4
115.65%
266.00
Jul 07, 2022
44.06M
Grant
Jul 05
Form 4
65.00K
Jun 08, 2022
65.00K
Grant
Jun 06
Form 4
230.00
Apr 06, 2022
44.06M
Grant
Apr 05
Form 4
12.50K
Apr 27, 2021
44.06M
Acq/Dis
Apr 21
Form 4/A
23.59K
Feb 18, 2021
23.59K
Grant
Feb 03
Form 4
Feb 10, 2021
44.04M
Options
Feb 08
Form 4
14.00K
Feb 05, 2021
14.00K
Grant
Feb 03
Form 3
Feb 03, 2021
292.50K
Showing 14 results

KYTHERA BIOPHARMACEUTICALS INC

Investor
Updated Mar 26, 2015
Form 4
11.97K
$18.08
$108.26K
Mar 26, 2015
10.30K
Options
Mar 24
Form 4
-33.21%
-473.23K
Mar 17, 2015
951.62K
Disposition
Mar 13
Form 4
-12.83%
-209.79K
Aug 18, 2014
1.42M
Disposition
Aug 14
Form 4
-8.73%
-156.41K
Jul 01, 2014
1.63M
Disposition
Jun 27
Form 4
8.40K
Jun 06, 2014
8.40K
Grant
Jun 05
Form 4
-14.94%
-314.69K
Mar 21, 2014
1.79M
Disposition
Mar 20
Form 4
6.62K
Jun 06, 2013
6.62K
Grant
Jun 04
Form 4
5.67K
Nov 02, 2012
5.67K
Grant
Oct 10
Form 4
-1.63%
-34.89K
$13.72
-$919.77K
Oct 16, 2012
2.11M
Options
Oct 16
Form 3
Oct 10, 2012
Showing 10 results

ALNYLAM PHARMACEUTICALS INC

Investor
Updated Jun 01, 2004
Form 3
Jun 01, 2004
222.50K
Showing 1 results

Lyell Immunopharma, Inc.

Investor
Updated Jun 17, 2024
Form 4
130.00K
Jun 17, 2024
36.54M
Grant
Jun 14
Form 4
55.00K
Sep 08, 2023
36.47M
Grant
Sep 08
Form 4
65.00K
Jun 20, 2023
36.48M
Grant
Jun 16
Form 4
65.00K
Jun 10, 2022
36.48M
Grant
Jun 08
Form 4
Jun 23, 2021
36.41M
Options
Jun 21
Form 3
Jun 16, 2021
Showing 6 results

AGIOS PHARMACEUTICALS INC

Investor
Updated Mar 07, 2017
Form 4
-100.00%
-40.60K
$50.84
-$2.06M
Mar 07, 2017
109.23K
Sale
Mar 03 - Mar 06
Form 4
-85.69%
-243.08K
$49.36
-$12.00M
Mar 01, 2017
149.83K
Sale
Feb 27 - Feb 28
Form 4
-15.81%
-73.80K
$49.37
-$6.68M
Feb 23, 2017
392.91K
Sale
Jun 30 - Feb 23
Form 4
34.59%
8.00K
Jun 23, 2016
31.13K
Grant
Jun 21
Form 4
85.00%
10.63K
Jun 25, 2015
23.13K
Grant
Jun 23
Form 4
-30.40%
-732.90K
Jun 19, 2015
1.68M
Disposition
Jun 17 - Jun 18
Form 4
-11.01%
-298.27K
Jun 02, 2015
2.41M
Disposition
May 29
Form 4
-12.41%
-383.85K
May 13, 2015
2.71M
Disposition
May 11
Form 4
-11.04%
-383.84K
Feb 23, 2015
3.09M
Disposition
Feb 19
Form 4
-9.94%
-383.84K
Jun 25, 2014
3.48M
Disposition
Jun 23
Form 4
12.50K
Jun 05, 2014
12.50K
Grant
May 30
Form 4
-63.64%
-6.76M
Jul 31, 2013
3.86M
Options
Jul 29
Form 3
Jul 23, 2013
Showing 13 results

DA32 Life Science Tech Acquisition Corp.

Investor
Updated Aug 10, 2023
Form 4
-100.00%
-1.60M
Aug 10, 2023
650.00K
Disposition
Jul 28
Form 4
-13.57%
-701.25K
Aug 09, 2021
4.47M
Disposition
Aug 05
Form 4
140.63%
2.25M
$10.00
$22.50M
Aug 03, 2021
3.85M
Purchase
Jul 30
Form 3
Jul 27, 2021
Showing 4 results

908 Devices Inc.

Investor
Updated Dec 22, 2020
Form 4
5.53%
300.00K
$20.00
Dec 22, 2020
5.73M
Purchase
Dec 22
Form 3
Dec 17, 2020
Showing 2 results

Karuna Therapeutics, Inc.

Investor
Updated Apr 15, 2021
Form 4
-4.83%
-148.24K
Apr 15, 2021
2.92M
Disposition
Apr 13
Form 4
-4.61%
-148.24K
Jan 12, 2021
3.07M
Disposition
Jan 08
Form 4
-4.41%
-148.24K
Nov 16, 2020
3.21M
Disposition
Nov 12
Form 4
12.50K
Jun 08, 2020
12.50K
Grant
Jun 04
Form 4
23.08%
927.46K
$16.00
$1.60M
Jul 02, 2019
4.95M
Purchase
Jul 02
Form 4
16.25K
Jul 01, 2019
16.25K
Grant
Jun 27
Form 3
Jun 27, 2019
Showing 7 results

Quanterix Corp

Investor
Updated Nov 24, 2020
Form 4
-10.97%
-825.66K
Nov 24, 2020
6.70M
Disposition
Nov 20 - Nov 24
Form 4
-66.64%
-7.89M
$15.00
Dec 13, 2017
3.95M
Buy-Options
Dec 11
Form 3
Dec 06, 2017
Showing 3 results

Revolution Healthcare Acquisition Corp.

Investor
Updated Mar 17, 2021
Form 3
Mar 17, 2021
Showing 1 results

Denali Therapeutics Inc.

Investor
Updated Jun 04, 2021
Form 4
80.09%
8.30K
Jun 04, 2021
9.69M
Grant
Jun 02
Form 4
-9.32%
-994.92K
Jun 03, 2021
9.68M
Options
Mar 22 - Jun 01
Form 4
18.44K
Jun 05, 2020
18.44K
Grant
Jun 03
Form 4
-3.60%
-397.97K
Aug 12, 2019
10.67M
Disposition
Aug 08
Form 4
27.25K
Jun 03, 2019
27.25K
Grant
May 30
Form 4
27.83K
Jun 15, 2018
27.83K
Grant
Jun 13
Form 4
Dec 12, 2017
11.07M
Options
Dec 12
Form 4
47.16K
Dec 08, 2017
47.17K
Grant
Dec 07
Form 3
Dec 07, 2017
312.50K
Showing 9 results

FATE THERAPEUTICS INC

Investor
Updated Oct 07, 2013
Form 4
67.46%
996.26K
$6.00
Oct 07, 2013
2.47M
Purchase
Oct 04
Form 3
Sep 30, 2013
Showing 2 results

Twist Bioscience Corp

Investor
Updated Nov 06, 2018
Form 4
2.28%
75.00K
$14.00
Nov 06, 2018
3.36M
Purchase
Nov 02
Form 3
Oct 30, 2018
Showing 2 results

Sage Therapeutics, Inc.

Investor
Updated Nov 12, 2015
Form 4
-27.80%
-474.59K
Nov 12, 2015
1.23M
Disposition
Nov 09
Form 4
-21.72%
-474.59K
Sep 29, 2015
1.71M
Disposition
Sep 25
Form 4
-31.58%
-1.01M
Jun 22, 2015
2.18M
Disposition
Jun 18
Form 4
13.92K
$73.13
$1.02M
Jun 01, 2015
13.92K
Grant
May 28
Form 4
-24.86%
-1.06M
Jan 16, 2015
3.19M
Disposition
Jan 14
Form 4
-68.25%
-9.14M
Jul 23, 2014
4.25M
Options
Jul 23
Form 3
Jul 17, 2014
Showing 7 results

Vir Biotechnology, Inc.

Investor
Updated Jun 03, 2024
Form 4
4.17%
24.00K
Jun 03, 2024
13.55M
Grant
May 30
Form 4
3.17%
18.08K
May 24, 2023
13.54M
Grant
May 22
Form 4
-3.37%
-941.67K
Sep 07, 2022
27.02M
Disposition
Sep 02 - Sep 06
Form 4
-3.15%
-941.65K
Sep 01, 2022
28.91M
Disposition
Aug 30 - Aug 31
Form 4
-2.96%
-941.65K
Aug 26, 2022
30.85M
Disposition
Aug 24 - Aug 25
Form 4
-2.80%
-470.83K
Aug 22, 2022
16.35M
Disposition
Aug 18
Form 4
-2.69%
-1.41M
Aug 16, 2022
51.19M
Disposition
Aug 12 - Aug 16
Form 4
-2.52%
-470.83K
Jun 10, 2022
18.23M
Disposition
Jun 08
Form 4
-2.46%
-470.83K
Jun 06, 2022
18.70M
Disposition
Jun 02
Form 4
7.76%
19.21K
May 25, 2022
19.18M
Grant
May 23
Form 4/A
70.13%
102.04K
May 10, 2022
247.55K
Acquisition
Dec 20
Form 4
-7.92%
-1.65M
Dec 22, 2021
19.16M
Disposition
Dec 20
Form 4
-2.21%
-470.85K
Dec 01, 2021
20.81M
Disposition
Nov 29
Form 4
-2.16%
-470.85K
Nov 24, 2021
21.28M
Disposition
Nov 22
Form 4
-15.38%
-3.95M
Jul 06, 2021
21.75M
Disposition
Jul 01
Form 4
-3.70%
-988.03K
Jun 24, 2021
25.70M
Disposition
Jun 22
Form 4
42.26%
10.12K
May 25, 2021
26.70M
Grant
May 21
Form 4
-1.80%
-988.02K
Apr 09, 2021
53.86M
Disposition
Apr 07 - Apr 08
Form 4
-1.74%
-988.02K
Apr 01, 2021
55.85M
Disposition
Mar 30 - Apr 01
Form 4/A
24.89K
Oct 13, 2020
24.89K
Grant
May 21
Form 4
28.89K
May 26, 2020
28.89K
Grant
May 21
Form 4
3.61%
1.00M
$20.00
$20.00M
Oct 18, 2019
28.67M
Purchase
Oct 16
Form 3
Oct 10, 2019
444.44K
Showing 23 results

Bellerophon Therapeutics, Inc.

Investor
Updated Feb 23, 2015
Form 4
14.12%
212.67K
$12.00
$2.55M
Feb 23, 2015
1.72M
Purchase
Feb 12 - Feb 19
Form 3
Feb 13, 2015
752.99K
Showing 2 results

XCYTE THERAPIES INC

Investor
Updated Jun 17, 2005
Form 4
10.00K
Jun 17, 2005
10.00K
Grant
Jun 17
Form 4
30.72%
200.00K
$10.00
$2.00M
Nov 02, 2004
851.06K
Purchase
Oct 29
Form 4
-73.40%
-5.67M
$8.00
$1.50M
Mar 23, 2004
2.05M
Buy-Options
Mar 19
Form 3/A
Mar 16, 2004
Form 3
Mar 10, 2004
Showing 5 results

Juno Therapeutics, Inc.

Investor
Updated Mar 07, 2018
Form 4
-100.00%
-10.64M
$66.05
-$924.38M
Mar 07, 2018
Disposition
Mar 05
Form 4
0.44%
237.00
Jan 09, 2018
10.61M
Grant
Jan 05
Form 4
0.47%
254.00
Oct 10, 2017
10.61M
Grant
Oct 05
Form 4
0.75%
400.00
Jul 07, 2017
10.61M
Grant
Jul 05
Form 4
12.00K
Jun 19, 2017
12.00K
Grant
Jun 16
Form 4
1.09%
573.00
Apr 06, 2017
10.61M
Grant
Apr 05
Form 4
1.27%
659.00
Jan 09, 2017
10.60M
Grant
Jan 05
Form 4
0.87%
447.00
Oct 17, 2016
10.60M
Grant
Oct 05
Form 4
0.65%
335.00
Jul 05, 2016
10.60M
Grant
Jul 05
Form 4
12.00K
Jun 21, 2016
12.00K
Grant
Jun 17
Form 4
0.65%
329.00
Apr 07, 2016
10.60M
Grant
Apr 05
Form 4
12.00K
Jun 16, 2015
12.00K
Grant
Jun 12
Form 4
Dec 23, 2014
11.55M
Options
Dec 23
Form 3
Dec 18, 2014
1.10M
Showing 14 results

Prime Medicine, Inc.

Investor
Updated Jun 14, 2024
Form 4
45.00K
Jun 14, 2024
45.00K
Grant
Jun 12
Form 4
3.20M
$6.25
$20.00M
Feb 20, 2024
15.47M
Purchase
Feb 15
Form 4
39.06K
Jun 16, 2023
39.06K
Grant
Jun 14
Form 4
-65.59%
-23.39M
$17.00
Oct 26, 2022
12.27M
Buy-Options
Oct 24
Form 3/A
Oct 24, 2022
Form 3
Oct 19, 2022
Showing 6 results

ILLUMINA INC

Investor
Updated Feb 05, 2004
Form 4
-12.00%
-398.97K
Feb 05, 2004
2.93M
Disposition
Feb 03
Form 4
-8.25%
-299.23K
Dec 01, 2003
3.33M
Disposition
Nov 26
Form 4
May 27, 2003
Showing 3 results

ADOLOR CORP

Investor
Updated May 21, 2007
Form 4
1.77%
21.32K
May 21, 2007
1.23M
Grant
May 17
Form 4
15.00K
May 19, 2006
15.00K
Grant
May 18
Form 4
15.00K
Jun 16, 2005
15.00K
Grant
Jun 16
Form 4
15.00K
May 17, 2004
15.00K
Grant
May 13
Form 4
-5.18%
-22.00K
$19.11
-$420.35K
Dec 09, 2003
402.87K
Sale
Dec 08
Form 4
-10.64%
-146.23K
Nov 24, 2003
1.23M
Disposition
Nov 21
Showing 6 results